clofazimine has been researched along with tacrolimus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Benedix, F; Geyer, A; Lichte, V; Metzler, G; Röcken, M; Strölin, A | 1 |
| Ruiz Villaverde, R; Sánchez Cano, D | 1 |
| Colley, BS; Phillips, LL; Reeves, TM; Trimmer, PA | 1 |
| C Hofmann, S; Lehmann, P; Paschos, A | 1 |
1 review(s) available for clofazimine and tacrolimus
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
6 other study(ies) available for clofazimine and tacrolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Response of ulcerated necrobiosis lipoidica to clofazimine.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Clofazimine; Female; Humans; Immunosuppressive Agents; Necrobiosis Lipoidica; Stockings, Compression; Tacrolimus | 2009 |
Successful treatment of granulomatous cheilitis with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Biopsy; Clofazimine; Female; Histamine Antagonists; Humans; Melkersson-Rosenthal Syndrome; Middle Aged; Prednisone; Roxithromycin; Tacrolimus; Treatment Outcome; Triamcinolone | 2012 |
Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury.
Topics: Action Potentials; Animals; Animals, Newborn; Brain Injuries, Traumatic; Calcium-Binding Proteins; Cells, Cultured; Clofazimine; Corpus Callosum; Cyclosporine; Disease Models, Animal; Electric Stimulation; Gene Expression Regulation; Immunosuppressive Agents; Kv1.3 Potassium Channel; Leukoencephalopathies; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Tacrolimus | 2016 |
Cutaneous squamous cell carcinoma as a complication of discoid lupus erythematosus.
Topics: Administration, Topical; Adrenal Cortex Hormones; Aged; Antimalarials; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Clofazimine; Diabetic Retinopathy; Drug Therapy, Combination; Ear; Humans; Leprostatic Agents; Lupus Erythematosus, Discoid; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Skin Neoplasms; Tacrolimus; Treatment Outcome | 2019 |